New CMS Demo Aims to Increase Access to GLP-1s Under Medicaid and Part D

(MedPage Today) — The Trump administration announced a new demonstration program aimed at easing access to GLP-1 receptor agonists for enrollees in Medicare Part D and Medicaid plans, but experts say it’s unclear how popular or effective it will…

Source link : https://www.medpagetoday.com/publichealthpolicy/washington-watch/119239

Author :

Publish date : 2025-12-31 18:28:00

Copyright for syndicated content belongs to the linked Source.

M	T	W	T	F	S	S
						1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28	29
30	31

New CMS Demo Aims to Increase Access to GLP-1s Under Medicaid and Part D

What’s the Time Burden of Women’s Cancers-Related Tasks?

Israel Will Halt Doctors Without Borders Operations in Gaza

Related Posts

Sleep Apnea Measure May Predict Postop Complications, Death

Inhaled Vasodilator Slows Lung Function Decline in Idiopathic Pulmonary Fibrosis

Goodbye FAERS? FDA Launches New Combined Adverse Event Database

Lead Suits Cut Physician Radiation Exposure for Interventional Cardiology Cases

Traditional Medicare Enrollees Paid Billions More in Premiums Due to MA Overpayments

FDA Warns GLP-1 Maker Over Failure to Properly Report Deaths, Strokes

Sleep Apnea Measure May Predict Postop Complications, Death

Inhaled Vasodilator Slows Lung Function Decline in Idiopathic Pulmonary Fibrosis

Goodbye FAERS? FDA Launches New Combined Adverse Event Database

Lead Suits Cut Physician Radiation Exposure for Interventional Cardiology Cases

Traditional Medicare Enrollees Paid Billions More in Premiums Due to MA Overpayments

FDA Warns GLP-1 Maker Over Failure to Properly Report Deaths, Strokes

Apixaban Snags a Win in Head-to-Head Trial of Direct Oral Anticoagulants

Drug Cuts Treatment Modifications From Chemotherapy-Induced Thrombocytopenia

Categories

Archives